ARCHIVES

DCT Advisors Approve Grants Program For Trials Of BRMs

This article is from The Cancer Letter archive.

Vol. 21 No. 10 | March 10, 1995

Download PDF Visit The Full Archive

Related Articles

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

Vanderbilt-Ingram Cancer Center Wins NCI’s Comprehensive Designation.

March 16, 2001

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006